Denmark fell by the minimum against Finland, in the resumption of the game interrupted by the collapse of Eriksen

The NBA has completed a study with infectious disease specialists and test manufacturers on the results of preseason antibody tests of 2,300 players and staff, citing additional evidence of the need for booster doses of Covid-19 vaccines for staff of the NBA. the League, according to a copy of the study. findings obtained by ESPN.

The NBA study found that the Moderna and Pfizer vaccines created higher levels of antibodies compared to Johnson and Johnson and detailed the decline in antibodies over time. The NBA wanted to understand the effectiveness of different vaccines and what different antibody levels could mean for the risk of infection.

The NBA is aware of 34 cases of fully vaccinated players or staff who were infected with a groundbreaking case of Covid-19 as of Nov. 19, including 31 who had detectable levels of antibodies significantly lower than those seen in the remaining test population. , According to the report. Three of the 34 infections occurred with “undetected” antibody levels, according to the study.

The NBA has a 97 percent vaccination rate among its players, the league said. The NBA is using the report’s findings to encourage eligible players to follow the NBA / NBPA’s previous recommendation to receive a booster shot, and team doctors are expected to use these results to educate players on the importance. of additional vaccination protection.

Of the 2,388 people screened in the preseason, 75 produced “undetected” results, including 11 percent of whom had received the Johnson and Johnson vaccine. That percentage was considerably higher than those who received Pfizer (1 percent) and Moderna (0.2 percent).

Those results suggest that those who received the J&J vaccine at least two months ago, or a second dose of Pfizer or Moderna at least six months ago, are at increased risk for breakthrough infections.